$4.16
Today
as of Aug 5, 16:52 ET
Last 30 days
Recent Press Releases & News
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
Overview
52-week range
$1.91
$5.38
65% of range
Avg surprise (last 3)
-6.6%
Avg reaction (last 2)
-6.4%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-1.11 | $-0.81 | -37.0% | +6.7% | -1.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.09 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-1.14 | $-1.23 | +7.3% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $-1.19 | $-1.32 | +9.8% | — | -11.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-36.55 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-44.82 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-30.37 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-5.68 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.65 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.58 | -$1.14 | +49.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-16M | — | $-16M | $-16M | $-17M | — | $-12M | $-14M |
| Net income | $-15M | $-14M | $-15M | $-15M | $-16M | $-17M | $-12M | $-14M |
| EPS (diluted) | $-1.11 | — | $-1.09 | $-1.14 | $-1.19 | — | $-36.55 | $-44.82 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $192M | $59M | $70M | $83M | $97M | $111M | $61M | $36M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $197M | $61M | $72M | $85M | $98M | $113M | $77M | $78M |
| Total assets | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $14M | $6M | $6M | $8M | $9M | $11M | $4M | $2M |
| Total equity | $184M | $56M | $66M | $78M | $91M | $104M | $-135M | $-124M |
Implied volatility — last 90 days
No IV snapshots yet for OKUR.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.